Sep 3, 2026•1 min read
China’s Fast‑Follower Model Pressures Biotech IP Strategies
Intensifying global drug development competition highlights the need for strong patents, timed disclosures and strategic workarounds as China’s fast‑follower biotech sector accelerates patient recruitment and cuts clinical costs.